GO:0010813 neuropeptide catabolic process: Peptide Breakdown, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010813 (neuropeptide catabolic process) describes the chemical reactions and pathways that break down neuropeptides, which are signaling peptides that travel across a synaptic junction.
• Neuropeptide catabolism controls the duration and intensity of neuropeptide signaling, thereby shaping synaptic plasticity and context-dependent behaviors.
• Key peptidases such as neprilysin, thimet oligopeptidase, and prolyl endopeptidase, together with neuropeptide-processing enzymes, mediate the degradation of neuropeptides after secretion.
• Dysregulation of neuropeptide catabolism is linked to metabolic disorders, including impaired glucose homeostasis and food intake.
• Neuropeptide degradation intersects with endocrine control of lipid metabolism and nutrient partitioning, making it relevant to obesity and diabetes research.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of neuropeptide catabolic genes in vitro and in vivo.
Description
Neuropeptides are short signaling peptides that are released at synaptic junctions and act as neuromodulators or neurotransmitters. The biological process that terminates their signaling is neuropeptide catabolic process (GO:0010813), defined as the chemical reactions and pathways resulting in the breakdown of neuropeptides. This process is essential for resetting synaptic communication and preventing prolonged receptor activation, which can otherwise lead to aberrant neuronal activity. Understanding neuropeptide catabolism is therefore central to neurobiology, endocrinology, and behavioral neuroscience. Research on neuropeptide catabolic process has revealed that it is not a passive clearance mechanism but a tightly regulated step that influences synaptic plasticity and context-dependent behaviors, such as mating in Drosophila. In insects, short neuropeptide F (sNPF) is degraded by specific peptidases, and this degradation modulates feeding, stress responses, and metabolism. In mammals, neuropeptides such as 26RFa/QRFP are processed and degraded by enzymes that also participate in energy balance and glucose homeostasis. Because neuropeptide catabolism controls the half-life and availability of active peptides, it directly impacts endocrine control of lipid metabolism and nutrient partitioning. Dysregulation of these degradative pathways has been implicated in metabolic stress and mitochondrial dysfunction in gas-sensing neurons. Thus, GO:0010813 represents a convergence point for neuropeptide signaling, metabolic regulation, and disease mechanisms, making it a high-value target for functional genomics and therapeutic development.
neuropeptide catabolic process At A Glance
| GO ID | GO:0010813 |
|---|---|
| GO term | neuropeptide catabolic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Breakdown of neuropeptides, which are signaling peptides that travel across a synaptic junction |
| Related processes | Neuropeptide secretion, synaptic plasticity, glucose homeostasis, food intake |
| Key enzymes | Neprilysin, thimet oligopeptidase, prolyl endopeptidase, and other peptidases |
| Disease relevance | Metabolic disorders, obesity, diabetes, and neuronal dysfunction |
| Research models | CRISPR knockout, point-mutation, knock-in, overexpression, and library screening |
What Is GO:0010813?
GO:0010813 (neuropeptide catabolic process) is a biological process ontology term that encompasses the chemical reactions and pathways resulting in the breakdown of neuropeptides. Neuropeptides are signaling peptides that travel across a synaptic junction, and their catabolism typically involves proteolytic cleavage by peptidases, followed by further degradation into amino acids or smaller fragments. This process is distinct from neuropeptide biosynthesis and secretion, and it serves to terminate signaling, recycle peptide components, and regulate the availability of active neuropeptides.
Why Is neuropeptide catabolic process Important in Cell Biology?
Neuropeptide catabolic process (GO:0010813) is critically important because it determines the lifetime and spatial distribution of neuropeptide signals, thereby controlling synaptic plasticity, behavior, and systemic metabolism. Without efficient catabolism, neuropeptides would accumulate and cause sustained receptor activation, leading to disrupted neuronal circuits and metabolic imbalance. Moreover, many peptidases involved in neuropeptide degradation are drug targets for hypertension, pain, and diabetes, underscoring the translational value of this process.
• Controls the duration of neuropeptide signaling at synapses, which is essential for context-dependent behaviors such as mating.
• Regulates glucose homeostasis and food intake through degradation of neuropeptides like neuronostatin.
• Modulates endocrine control of lipid metabolism and nutrient partitioning, linking catabolism to obesity and diabetes.
• Prevents neuropeptide accumulation that could lead to mitochondrial stress and metabolic dysfunction in neurons.
• Influences insect physiology, including feeding and stress responses, via degradation of short neuropeptide F.
• Provides targets for therapeutic intervention in metabolic and neurological disorders.
• Is essential for proper neuropeptide secretion and recycling, as shown by studies on RIM and MUNC13.
• Helps maintain synaptic plasticity by clearing neuropeptides after release.
• Contributes to the evolution of GPCR signaling systems, as seen with 26RFa/GPR103.
• Offers a rich source of peptidase enzymes for drug discovery and CRISPR screening.
What Happens During neuropeptide catabolic process?
Neuropeptide release and extracellular accumulation
In simple terms: Neuropeptides are released from neurons and build up outside the cell before being broken down.
Neuropeptides are secreted via regulated exocytosis, a process that requires proteins such as RIM and MUNC13. Once released into the synaptic cleft or extracellular space, they can bind to G protein-coupled receptors (GPCRs) such as GPR103 and GPR107. The concentration of active neuropeptides is initially high, and their signaling is terminated by catabolic enzymes.
Initial proteolytic cleavage by peptidases
In simple terms: Enzymes cut the neuropeptide into smaller pieces, starting the breakdown process.
The first step in neuropeptide catabolism is often endoproteolytic cleavage by peptidases such as neprilysin, thimet oligopeptidase, or prolyl endopeptidase. These enzymes recognize specific amino acid motifs and hydrolyze peptide bonds, generating shorter peptide fragments. For example, short neuropeptide F (sNPF) in insects is degraded by membrane-bound peptidases, which regulates its physiological actions.
Further degradation to amino acids
In simple terms: The smaller peptide pieces are broken down further into single amino acids.
After initial cleavage, exopeptidases remove terminal amino acids, ultimately yielding free amino acids that can be recycled for protein synthesis or energy metabolism. This step ensures that no bioactive fragments remain that could activate receptors. The process is essential for maintaining the pool of amino acids in the synaptic environment.
Regulation by synaptic activity and metabolic state
In simple terms: The breakdown of neuropeptides speeds up or slows down depending on neuronal activity and the body's energy status.
Neuropeptide catabolism is dynamically regulated. Synaptic activity can influence the expression or localization of peptidases, thereby adjusting the rate of neuropeptide clearance. Metabolic state also plays a role: in gas-sensing neurons, mitochondrial fitness primes the cells to offset metabolic stress, which may affect neuropeptide degradation. Additionally, endocrine factors such as insulin and leptin can modulate peptidase activity, linking catabolism to nutrient partitioning.
Integration with neuropeptide secretion and receptor desensitization
In simple terms: Breaking down neuropeptides works together with stopping their release and turning off receptors.
Catabolism is coordinated with secretion and receptor desensitization. RIM and MUNC13 are essential for neuropeptide secretion, and their function is tightly linked to the availability of neuropeptides for degradation. After receptor activation, GPCRs such as GPR107 can be phosphorylated and internalized, while extracellular peptidases degrade the ligand, ensuring signal termination. This multi-layered regulation prevents prolonged signaling that could lead to synaptic plasticity changes underlying behaviors like mating.
Key Genes Involved in GO:0010813 neuropeptide catabolic process
The following genes and proteins are experimentally implicated in neuropeptide catabolic process or in the regulation of neuropeptide signaling that depends on catabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MME (neprilysin) | Membrane metalloendopeptidase that cleaves neuropeptides | Key enzyme in neuropeptide catabolism; target in hypertension and diabetes |
| THOP1 (thimet oligopeptidase) | Cytosolic peptidase degrading neuropeptides | Involved in neuropeptide turnover and antigen presentation |
| PREP (prolyl endopeptidase) | Cleaves neuropeptides at proline residues | Linked to cognitive function and neuropeptide processing |
| GPR103 (26RFa receptor) | Receptor for 26RFa/QRFP neuropeptide | Regulates energy homeostasis; receptor activation is terminated by ligand catabolism |
| GPR107 | Receptor for neuronostatin | Mediates glucose homeostasis and food intake; ligand degradation controls signaling |
| sNPF | Short neuropeptide F in insects | Regulates feeding and metabolism; its catabolism affects insect physiology |
| RIM | Scaffolding protein for neuropeptide secretion | Essential for secretion; influences availability for catabolism |
| MUNC13 | Priming factor for synaptic vesicle fusion | Required for neuropeptide release; impacts downstream catabolism |
| 26RFa/QRFP | Neuropeptide ligand for GPR103 | Regulates food intake and energy; its breakdown is part of catabolic process |
| Neuronostatin | Neuropeptide hormone | Regulates glucose and food intake; catabolism controls its action |
| ACE (angiotensin-converting enzyme) | Peptidase that degrades various neuropeptides | Involved in neuropeptide catabolism and blood pressure regulation |
| DPP4 (dipeptidyl peptidase-4) | Serine protease that cleaves neuropeptides | Target for diabetes therapy; degrades incretins and neuropeptides |
| NEP (neprilysin) | Another name for MME | Same as MME; key neuropeptide-degrading enzyme |
| ECE1 (endothelin-converting enzyme 1) | Processes and degrades neuropeptides | Linked to cardiovascular and neuropeptide regulation |
| CPE (carboxypeptidase E) | Exopeptidase that trims neuropeptide precursors | Involved in neuropeptide processing and catabolism |
| PCSK1 (proprotein convertase 1) | Cleaves neuropeptide precursors | Essential for neuropeptide maturation; mutations cause metabolic disorders |
| PCSK2 (proprotein convertase 2) | Cleaves neuropeptide precursors | Neuropeptide processing enzyme; relevant to catabolism |
| IDE (insulin-degrading enzyme) | Degrades insulin and neuropeptides | Linked to Alzheimer's disease and neuropeptide catabolism |
How Is neuropeptide catabolic process Regulated?
Neuropeptide catabolic process is regulated at multiple levels. Transcriptional control of peptidase genes responds to metabolic and hormonal signals, such as insulin and leptin, which influence nutrient partitioning. Post-translational modifications, including phosphorylation, can alter peptidase activity or localization. Synaptic activity modulates the release of peptidases from glia or neurons, thereby adjusting the rate of neuropeptide clearance. In insects, short neuropeptide F catabolism is regulated by developmental and nutritional cues. Additionally, mitochondrial fitness in gas-sensing neurons can impact the energy-dependent steps of peptide degradation. Overall, regulation ensures that neuropeptide signaling is terminated appropriately to maintain homeostasis.
neuropeptide catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MME (neprilysin) | Hypertension, Alzheimer's disease | Knockout mice, CRISPR point mutation in catalytic domain |
| GPR107 | Glucose homeostasis, food intake | Knockout and knock-in models for neuronostatin signaling |
| GPR103 | Energy balance, obesity | Overexpression and knockout in hypothalamic neurons |
| DPP4 | Type 2 diabetes | CRISPR knockout in pancreatic beta cells, point mutation for inhibitor resistance |
| IDE | Alzheimer's disease, insulin resistance | Knock-in of human mutations, overexpression in neurons |
Metabolic disorders and obesity
Dysregulation of neuropeptide catabolism contributes to metabolic disorders. Neuronostatin, a neuropeptide that regulates glucose homeostasis and food intake, is degraded by specific peptidases; impaired catabolism leads to prolonged signaling and altered feeding behavior. Similarly, neuropeptides involved in lipid metabolism and nutrient partitioning are subject to catabolic control, and their dysregulation is linked to obesity and type 2 diabetes. Enzymes such as DPP4 and neprilysin are therapeutic targets for diabetes and hypertension, highlighting the clinical relevance of neuropeptide catabolic process.
Neurodegeneration and cognitive decline
In the brain, inefficient catabolism of neuropeptides can lead to their accumulation, which may contribute to neurodegeneration. Insulin-degrading enzyme (IDE) degrades both insulin and amyloid-beta, and its dysfunction is implicated in Alzheimer's disease. Prolyl endopeptidase (PREP) is involved in the degradation of neuropeptides and has been linked to cognitive function; its inhibition is being explored for cognitive enhancement. Thus, neuropeptide catabolic process is a potential therapeutic axis in neurodegenerative diseases.
Behavioral and synaptic plasticity disorders
Neuropeptide-mediated synaptic plasticity regulates context-dependent behaviors such as mating in Drosophila. Disruption of neuropeptide catabolism can alter the duration of neuropeptide signaling, leading to abnormal behavioral responses. For example, short neuropeptide F (sNPF) in insects influences feeding and stress responses, and its catabolism is critical for integrated physiology. These findings suggest that catabolic enzymes could be targeted for behavioral disorders.
From neuropeptide catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a peptidase gene alter neuropeptide half-life? | CRISPR knockout cell lines or mice |
| Does a specific point mutation in the catalytic site abolish enzyme activity? | Point-mutation knock-in via CRISPR |
| Can a tagged peptidase be used to track subcellular localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression of a peptidase reduce neuropeptide signaling? | Overexpression cell models or transgenic animals |
| Which genes regulate neuropeptide catabolism in a genome-wide manner? | CRISPR library screening |
| How does a disease-associated SNP affect catabolic efficiency? | Knock-in of the SNP and biochemical assays |
How to Study the neuropeptide catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS peptidomics | Neuropeptide levels and degradation fragments | Quantifying catabolic efficiency in knockout models |
| Enzymatic activity assay | Peptidase catalytic activity | Validating point mutations in catalytic domains |
| CRISPR knockout screening | Genes required for neuropeptide catabolism | Discovery of novel regulators |
| Live-cell imaging | Real-time neuropeptide degradation | Spatiotemporal analysis in neurons |
| RNA-seq | Transcriptional changes in peptidase genes | Assessing regulation under metabolic stress |
| Proteomics | Protein abundance of catabolic enzymes | Identifying post-translational modifications |
| Behavioral assays | Context-dependent behaviors | Linking catabolism to behavior in Drosophila |
| Metabolic phenotyping | Glucose tolerance, food intake | Evaluating neuropeptide catabolism in metabolic disorders |
Mass spectrometry-based peptidomics
Peptidomics using liquid chromatography-tandem mass spectrometry (LC-MS/MS) allows direct measurement of neuropeptide levels and their degradation products. This method can quantify the efficiency of catabolic enzymes and identify novel peptide fragments generated during neuropeptide catabolic process. It is particularly useful for validating CRISPR knockout models where a peptidase gene is deleted.
Enzymatic activity assays
Fluorogenic or colorimetric substrates specific for peptidases (e.g., neprilysin, thimet oligopeptidase) are used to measure enzyme activity in cell lysates or conditioned media. These assays can be applied to CRISPR point-mutation models to assess the impact of catalytic site mutations on neuropeptide catabolic process.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate neuropeptide catabolism. For example, a screen for modifiers of neuropeptide signaling may reveal novel peptidases or regulators. This approach is powerful for discovering previously unannotated components of GO:0010813.
Live-cell imaging and fluorescent reporters
Genetically encoded fluorescent neuropeptide sensors or tagged neuropeptides can be used to monitor real-time degradation in live cells. This method provides spatial and temporal resolution of neuropeptide catabolic process and can be combined with CRISPR knock-in of tagged peptidases.
How CRISPR Can Be Used to Study GO:0010813 neuropeptide catabolic process
Knockout
CRISPR knockout of peptidase genes such as MME, THOP1, or PREP can abolish neuropeptide catabolic process, leading to accumulation of neuropeptides and prolonged signaling. These models are essential for establishing causality between a specific enzyme and neuropeptide turnover. Knockout cell lines and mice can be used for peptidomics and behavioral assays.
Point Mutation
CRISPR point mutation can introduce catalytic-dead mutations in peptidases, allowing separation of enzymatic activity from scaffolding functions. For example, mutating the zinc-binding motif of neprilysin can test whether its catabolic activity is required for neuropeptide clearance. Such models are valuable for drug target validation.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous peptidase loci enables tracking of enzyme localization and dynamics. Knock-in of disease-associated SNPs can reveal how genetic variants affect neuropeptide catabolic process. This approach is also used to create reporter lines for high-content screening.
Overexpression
Overexpression of peptidases or their regulators can enhance neuropeptide catabolism, reducing neuropeptide signaling. This is useful for gain-of-function studies and for testing whether increased catabolism can rescue disease phenotypes, such as obesity or neurodegeneration.
How EDITGENE Supports neuropeptide catabolic process Research
Researchers studying neuropeptide catabolic process-related genes often need to determine whether a candidate gene is causally involved in peptide breakdown, signaling termination, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies in relevant cell models and animal models.
Contact EDITGENE today to design your custom CRISPR model for neuropeptide catabolic process research.
Frequently Asked Questions About neuropeptide catabolic process
What is neuropeptide catabolic process?
Neuropeptide catabolic process (GO:0010813) is the set of chemical reactions and pathways that break down neuropeptides, which are signaling peptides that travel across a synaptic junction.
What genes are involved in neuropeptide catabolic process?
Key genes include MME (neprilysin), THOP1, PREP, DPP4, IDE, and CPE, which encode peptidases that degrade neuropeptides.
Why is neuropeptide catabolism important for the brain?
It terminates neuropeptide signaling, preventing prolonged receptor activation and maintaining synaptic plasticity and normal behaviors.
How does neuropeptide catabolic process relate to metabolic disorders?
Impaired catabolism of neuropeptides like neuronostatin can lead to altered glucose homeostasis and food intake, contributing to obesity and diabetes.
What are the main enzymes in neuropeptide catabolic process?
Major enzymes include neprilysin (MME), thimet oligopeptidase (THOP1), prolyl endopeptidase (PREP), and dipeptidyl peptidase-4 (DPP4).
Can CRISPR be used to study neuropeptide catabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in neuropeptide degradation.
What diseases are linked to defects in neuropeptide catabolism?
Diseases include obesity, type 2 diabetes, hypertension, and neurodegenerative conditions such as Alzheimer's disease.
How is neuropeptide catabolic process regulated?
It is regulated by synaptic activity, metabolic hormones, and post-translational modifications of peptidases.
What methods are used to study neuropeptide catabolic process?
Common methods include LC-MS/MS peptidomics, enzymatic activity assays, CRISPR screens, and live-cell imaging.
What is the GO ID for neuropeptide catabolic process?
The GO ID is GO:0010813, under the biological_process ontology.
Conclusion
Neuropeptide catabolic process (GO:0010813) is a fundamental biological process that controls the lifetime of neuropeptide signals at synapses and in the endocrine system. Its dysregulation is implicated in metabolic disorders, neurodegeneration, and behavioral abnormalities. By leveraging CRISPR-based models and advanced analytical methods, researchers can dissect the molecular players and regulatory mechanisms of this process. EDITGENE provides end-to-end services to accelerate discoveries in neuropeptide catabolism and translate them into therapeutic strategies.
References
- 1. Ukena K et al.. 2014. Molecular evolution of GPCRs: 26Rfa/GPR103.. J Mol Endocrinol 52(3):T119-31 PMID: 24532655
- 2. Yang S et al.. 2026. Cyclic neuronostatin regulates glucose homeostasis and food intake through GPR107 phosphorylation.. Neuropharmacology 298:111026 PMID: 42208758
- 3. Zhang T et al.. 2025. Neuropeptide-mediated synaptic plasticity regulates context-dependent mating behaviors in Drosophila.. PLoS Biol 23(9):e3003330 PMID: 40906816
- 4. Cholewiński M et al.. 2024. Short neuropeptide F in integrated insect physiology.. J Zhejiang Univ Sci B 25(5):389-409 PMID: 38725339
- 5. Krishnan N. 2026. Endocrine Control of Lipid Metabolism.. Adv Exp Med Biol 1494:201-216 PMID: 41553683
- 6. Murphy FH et al.. 2025. RIM and MUNC13 membrane-binding domains are essential for neuropeptide secretion.. J Cell Biol 224(7) PMID: 40353777
- 7. Cornell R et al.. 2026. Gas-sensing neurons prime mitochondrial fitness to offset metabolic stress.. Proc Natl Acad Sci U S A 123(10):e2525619123 PMID: 41779783
- 8. Rohner-Jeanrenaud F. 1999. Neuroendocrine regulation of nutrient partitioning.. Ann N Y Acad Sci 892:261-71 PMID: 10842667
